Nasdaq stss.

Sharps Technology Inc. Common Stock (STSS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. View real-time STSS stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...https://sharpstechnology.com. Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.

Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by...

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.. On July 12, 2023, Sharps Technology, Inc. (the “Company”) received a notice (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq ...WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a …

Dave Gentry. RedChip Companies Inc. 1-800-RED-CHIP (733-2447) Or 407-491-4498. [email protected]. First product shipped from Sharps' facility in Hungary and first to support the Nephron ...Sharp Technology (NASDAQ:STSS) soared 13% on Tuesday as the medical device company announced a deal to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility.On Invalid Date, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings per share (EPS) of -$0.22, up 466.67% year over year. Total Sharps Technology earnings for the quarter were -$2.61 million. In the same quarter last year, Sharps Technology's earnings per share (EPS) was $0.06.Nov 24, 2023 · BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory. GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a... The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.

Sharps Technology Inc. Common Stock (STSS) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.

08.06.2022 - NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) - Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented ...

Find the latest Revenue & EPS data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.Jan 30, 2023 · By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets. The company operates two primary syringe-based platforms which includes pre-filled syringes and smart safety syringes. In November 2022, Sharps entered into an impactful manufacturing and research With An Accelerated Near-Term Path For Product Commercialization And Expanded Manufacturing Capacity, Sharps Technology, Inc. (NASDAQ: STSS) Will Have The Ability To Support The Industry With ...The common stock and warrants are expected to begin trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Story continues.Find the latest analyst research for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com.RedChip Exclusive Investor Zoom Group Call Calendar ; OTC: EBZT - Everything Blockchain · Upcoming ; Thursday December 14, 2023 4:15 PM ET, NASDAQ: STSS - Sharps ...

Jan 13, 2023 · NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ... Sharps Technology Inc. Common Stock (STSS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Nov 17, 2023 · markets.businessinsider.com - September 15 at 10:14 AM. Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying. benzinga.com - September 10 at 7:40 AM. Multiple insiders bought Sharps Technology, Inc. (NASDAQ:STSS) stock earlier this year, a positive sign for shareholders. finance.yahoo.com - July 15 at 8:36 AM. NASDAQ: Sharps Technology Inc (STSS) = 0.46 USD. Provided by Alpha Vantage. Sharps Technology Inc stock (STSS) in USD. 1 STSS = 0.46 USD. 1 tháng. 6 tháng. 1 year. 5 năm. Hold over 40 currencies to convert and send money at any time. Open an account. Sharps Technology Inc stock performance at a glance. Check Sharps Technology Inc’s past …Sharps Technology Inc. Common Stock (STSS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.

STSS-14.53%: During Wednesday's pre-market session, the shares of SHARPS TECHNOLOGY INC (NASDAQ:STSS) declined by 14.53%, reaching $0.7. Following yesterday's gain of 26.19%, NASDAQ:STSS experiences a 14.53% decrease in today's pre-market session, indicating a pullback from the previous session's performance.(NASDAQ: STSS) closed up 6.15% at $1.90/share. Sharps Technology opened at $1.85/share. Bookable gains for our group of 2.7% on day one of our coverage. As I write this STSS is on the move in pre market trading at $1.94/share. Although STSS may need a little time for the chart to cool off at some point. We see this as one to keep …NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company ...Nov 10, 2023 · STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales Find the latest Financials data for Sharps Technology Inc. Common Stock (STSS) at Nasdaq.com. Nov 17, 2023 · markets.businessinsider.com - September 15 at 10:14 AM. Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying. benzinga.com - September 10 at 7:40 AM. Multiple insiders bought Sharps Technology, Inc. (NASDAQ:STSS) stock earlier this year, a positive sign for shareholders. finance.yahoo.com - July 15 at 8:36 AM. Shares of Sharps Technology, Inc. (NASDAQ:STSS) were down 35% to $0.5301 after the company reported a $5.6 million registered direct and private placement priced at the market under Nasdaq rules. ...NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...Nov 29, 2023 · Sharps Technology's stock was trading at $1.21 at the beginning of 2023. Since then, STSS stock has decreased by 63.6% and is now trading at $0.44. View the best growth stocks for 2023 here.

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into a definitive agreement with institutional investors for …

Jan 30, 2023 · By Thomas Kerr, CFA NASDAQ:STSS OVERVIEW Sharps Technology, Inc. (NASDAQ:STSS) is a medical device company specializing in drug delivery technology for the pharmaceutical and healthcare markets.

Apr 14, 2022 · Sharps Technology, Inc. (Nasdaq: STSS) is a medical device company that designs and manufactures smart safety syringes. Sharps Technology’s products are designed to eliminate infectious ... STSS Sharps Technology Inc. 0.80-0.0099 (-1.22%) After Hours. Last Updated: 17:40:18. Delayed by 15 minutes ...On Invalid Date, Sharps Technology (NASDAQ: STSS) reported Q2 2023 earnings per share (EPS) of -$0.22, up 466.67% year over year. Total Sharps Technology earnings for the quarter were -$2.61 million. In the same quarter last year, Sharps Technology's earnings per share (EPS) was $0.06.On October 5, 2023, Sharps Technology Inc. (NASDAQ: STSS) made a significant move by venturing into the copolymer prefillable syringe market.This strategic decision was made possible through a partnership with Nephron Pharmaceuticals Corp., a renowned player in generic medication contract manufacturing and 503B outsourcing, particularly in the …The latest price target for Sharps Technology ( NASDAQ: STSS) was reported by Aegis Capital on Tuesday, May 9, 2023. The analyst firm set a price target for 16.00 expecting STSS to rise to within ...STSSNASDAQ STSSNASDAQ 0.4428USD −0.0072 −1.60% Last update at Nov 22, 13:00 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast STSS …BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory. GAITHERSBURG, Md., June 05, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a digital technology company using machine learning to usher in a...Sharps Technology, Inc.(NASDAQ: STSS) Sharps Technology, Inc.(NASDAQ: STSS) is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. Sharps Provensa™ is the Company's premier line of smart safety syringes that eliminate …

Feb 9, 2023 · STSS Sharps Technology Inc Sharps Technology Appoints Justin Page as Vice President of Technical Operations NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the 'Company', 'Sharps') (NASDAQ: 'STSS' and 'STSSW'), an innovative medical device and drug delivery Company offering patented, ... NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, today announced that it closed its previously announced private placement pursuant to a securities …Jul 12, 2023 · STSS Sharps Technology Inc Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the mark... Instagram:https://instagram. arr stock newsfinancial advisor charlestonfree paper trading simulatoribaay Sharps Technology, Inc. (Nasdaq: STSS) is a medical device company that designs and manufactures smart safety syringes. Sharps Technology’s products are designed to eliminate infectious ...View real-time STSS stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ... sidecar health reviewsmichael kors owner Sharps Technology Inc. Common Stock (STSS) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into a definitive agreement with institutional investors for … fidelity freedom 2065 NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering ...Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, and Nephron Pharmaceuticals Corporation, (“Nephron”) a privately owned U.S. leader in contract manufacturing and 503B outsourcing, announce the signing of an Asset Purchase Agreement (APA) to ...Apr 14, 2022 · The common stock and warrants are expected to begin trading on The Nasdaq Capital Market on April 14, 2022, under the symbols “STSS” and “STSSW,” respectively. Story continues.